238 related articles for article (PubMed ID: 24595352)
1. Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice.
Hall AM; Soufi N; Chambers KT; Chen Z; Schweitzer GG; McCommis KS; Erion DM; Graham MJ; Su X; Finck BN
Diabetes; 2014 Jul; 63(7):2284-96. PubMed ID: 24595352
[TBL] [Abstract][Full Text] [Related]
2. Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1.
Lutkewitte AJ; Singer JM; Shew TM; Martino MR; Hall AM; He M; Finck BN
Mol Metab; 2021 Jul; 49():101204. PubMed ID: 33676028
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice.
Soufi N; Hall AM; Chen Z; Yoshino J; Collier SL; Mathews JC; Brunt EM; Albert CJ; Graham MJ; Ford DA; Finck BN
J Biol Chem; 2014 Oct; 289(43):30177-88. PubMed ID: 25213859
[TBL] [Abstract][Full Text] [Related]
4. Mogat1 deletion does not ameliorate hepatic steatosis in lipodystrophic (Agpat2-/-) or obese (ob/ob) mice.
Agarwal AK; Tunison K; Dalal JS; Yen CL; Farese RV; Horton JD; Garg A
J Lipid Res; 2016 Apr; 57(4):616-30. PubMed ID: 26880786
[TBL] [Abstract][Full Text] [Related]
5. Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver.
Hall AM; Kou K; Chen Z; Pietka TA; Kumar M; Korenblat KM; Lee K; Ahn K; Fabbrini E; Klein S; Goodwin B; Finck BN
J Lipid Res; 2012 May; 53(5):990-999. PubMed ID: 22394502
[TBL] [Abstract][Full Text] [Related]
6. Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia/Reperfusion Injury in Mice With Hepatic Steatosis.
Liss KHH; Ek SE; Lutkewitte AJ; Pietka TA; He M; Skaria P; Tycksen E; Ferguson D; Blanc V; Graham MJ; Hall AM; McGill MR; McCommis KS; Finck BN
Liver Transpl; 2021 Jan; 27(1):116-133. PubMed ID: 32916011
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
[TBL] [Abstract][Full Text] [Related]
8. Hepatic monoacylglycerol acyltransferase 1 is induced by prolonged food deprivation to modulate the hepatic fasting response.
Lutkewitte AJ; McCommis KS; Schweitzer GG; Chambers KT; Graham MJ; Wang L; Patti GJ; Hall AM; Finck BN
J Lipid Res; 2019 Mar; 60(3):528-538. PubMed ID: 30610082
[TBL] [Abstract][Full Text] [Related]
9. Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.
Popov VB; Jornayvaz FR; Akgul EO; Kanda S; Jurczak MJ; Zhang D; Abudukadier A; Majumdar SK; Guigni B; Petersen KF; Manchem VP; Bhanot S; Shulman GI; Samuel VT
FASEB J; 2016 Mar; 30(3):1207-17. PubMed ID: 26644352
[TBL] [Abstract][Full Text] [Related]
10. CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance.
Cantley JL; Yoshimura T; Camporez JP; Zhang D; Jornayvaz FR; Kumashiro N; Guebre-Egziabher F; Jurczak MJ; Kahn M; Guigni BA; Serr J; Hankin J; Murphy RC; Cline GW; Bhanot S; Manchem VP; Brown JM; Samuel VT; Shulman GI
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1869-74. PubMed ID: 23302688
[TBL] [Abstract][Full Text] [Related]
11. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.
Masuda S; Fujishima Y; Maeda N; Tsugawa-Shimizu Y; Nakamura Y; Tanaka Y; Obata Y; Fukuda S; Nagao H; Kita S; Nishizawa H; Shimomura I
Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E239-E250. PubMed ID: 30457913
[TBL] [Abstract][Full Text] [Related]
12. JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis.
Okuma C; Ohta T; Tadaki H; Ishigure T; Sakata S; Taniuchi H; Sano R; Hamada H; Kume S; Nishiu J; Kakutani M
J Pharmacol Sci; 2015 Jul; 128(3):150-7. PubMed ID: 26215699
[TBL] [Abstract][Full Text] [Related]
13. Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice.
Wu CY; Tso SC; Chuang JL; Gui WJ; Lou M; Sharma G; Khemtong C; Qi X; Wynn RM; Chuang DT
Mol Metab; 2018 Jun; 12():12-24. PubMed ID: 29656110
[TBL] [Abstract][Full Text] [Related]
14. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
[TBL] [Abstract][Full Text] [Related]
15. Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity.
Wendel AA; Li LO; Li Y; Cline GW; Shulman GI; Coleman RA
Diabetes; 2010 Jun; 59(6):1321-9. PubMed ID: 20200319
[TBL] [Abstract][Full Text] [Related]
16. Carboxylesterase 2a deletion provokes hepatic steatosis and insulin resistance in mice involving impaired diacylglycerol and lysophosphatidylcholine catabolism.
Chalhoub G; Jamnik A; Pajed L; Kolleritsch S; Hois V; Bagaric A; Prem D; Tilp A; Kolb D; Wolinski H; Taschler U; Züllig T; Rechberger GN; Fuchs C; Trauner M; Schoiswohl G; Haemmerle G
Mol Metab; 2023 Jun; 72():101725. PubMed ID: 37059417
[TBL] [Abstract][Full Text] [Related]
17. Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase.
Yen CL; Stone SJ; Cases S; Zhou P; Farese RV
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8512-7. PubMed ID: 12077311
[TBL] [Abstract][Full Text] [Related]
18. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
[TBL] [Abstract][Full Text] [Related]
19. Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling.
Yao Y
Mol Med Rep; 2020 Mar; 21(3):1059-1070. PubMed ID: 32016448
[TBL] [Abstract][Full Text] [Related]
20. Catalytic properties of MGAT3, a putative triacylgycerol synthase.
Cao J; Cheng L; Shi Y
J Lipid Res; 2007 Mar; 48(3):583-91. PubMed ID: 17170429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
